Lately, Wall Street economic commentary has been replete with ominous warnings. President Donald Trump’s tariffs are bound to cause an economic downturn, or perhaps even a recession.

The Wall Street Journal’s conservative editorial board continued with its needling of Donald Trump on Wednesday, this time explaining in a scathing article why it believes the president’s planned expansion of drug price controls should be a no-go.

Wall Street's main indexes fell on Tuesday after U.S. President Donald Trump's latest plans for pharma tariffs renewed worries of the impact of a trade war, while some downbeat corporate results also weighed on investor sentiment.